Neuhausen (CH)
{name}
{subtitle}
Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)
city
~18 mi. (Winterthur, Switzerland, +199 more cities)
facility
Kantonsspital Winterthur ( Site 0714)
condition
Hepatocellular Carcinoma
drug
pembrolizumab
drug type
immunotherapy
Efficacy and Safety Study of Stereotactic Body Radiotherapy (SBRT) With or Without Pembrolizumab (MK-3475) in Adults With Unresected Stage I or II Non-Small Cell Lung Cancer (NSCLC) (MK-3475-867/KEYNOTE-867)
city
~29 mi. (Eßlingen, Germany, +145 more cities)
facility
Klinikum Esslingen-Klinik für Kardiologie und Pneumologie ( Site 1208)
condition
Non-Small Cell Lung Carcinoma
drug
pembrolizumab, +1 more drug
drug type
immunotherapy, +2 more types
Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689)
city
~30 mi. (Zürich, Switzerland, +150 more cities)
facility
Universitaetsspital Zurich ( Site 1923)
condition
Head and Neck Squamous Cell Carcinoma
drug
cisplatin, +2 more drugs
drug type
chemotherapy, +2 more types
A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML)
city
~30 mi. (Zürich, Switzerland, +127 more cities)
facility
Universitätsspital Zürich /ID# 215891
condition
Acute Myeloid Leukemia
drug
azacitidine, +2 more drugs
drug type
chemotherapy
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
city
~30 mi. (Zürich, Switzerland, +105 more cities)
facility
Universitaetsspital Zuerich ( Site 1400)
biomarker
ATM Loss, +62 more biomarkers
condition
Breast Carcinoma, +2 more conditions
drug
olaparib
drug type
targeted therapy
Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004)
city
~30 mi. (Zürich, Switzerland, +34 more cities)
facility
UniversitätsSpital Zürich-Gastroenterologie & Hepatologie ( Site 0332)
condition
Hepatocellular Carcinoma
drug
lenvatinib, +2 more drugs
drug type
immunotherapy, +1 more type
A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory Malignancies
city
~30 mi. (Zürich, Switzerland, +29 more cities)
facility
Kinderspital Zurich - Eleonorenstiftung /ID# 163037
condition
Cancer
drug
chemotherapy, +1 more drug
drug type
chemotherapy